Logo

Castle Biosciences

Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic

The company's DecisionDx-SCC is meant to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors.

People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More

Castle Biosciences to Expand Range of Dermatology Diagnostics Beyond Cancer
Premium

The company said it is developing a new genomic test to predict therapeutic response in patients with inflammatory skin conditions.

Castle Biosciences Q1 Revenues Up 31 Percent

The company said it delivered 11 percent fewer DecisionDx-Melanoma test results year over year, but that the total number of all tests delivered rose 4 percent.

Castle Biosciences Acquires Myriad Genetics' MyPath Melanoma Test, Lab for $32.5M

The sale, part of Myriad's planned strategic refocusing of its business, will allow Castle to bolster its pipeline of tests for dermatologic cancers.

Apr 16, 2021

People in the News: New Appointments at ACMG, InterVenn Biosciences, Castle Biosciences, More

Mar 8, 2021

Castle Biosciences Q4 Revenues Down 2 Percent

Jan 4, 2021

GenomeWeb Index Ends 2020 on Upswing With Pacific Biosciences in Lead

Dec 23, 2020

In Brief This Week: Natera, Sync for Genes, Castle Biosciences, BioMérieux, PathogenDx, More

Dec 16, 2020

Castle Biosciences Prices $232M Public Offering of Common Stock

Dec 3, 2020

Local Coverage Determinations Roundup: Castle Bio

Nov 9, 2020

Castle Biosciences Q3 Revenues Up 3 Percent

Nov 6, 2020

Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests

Oct 22, 2020

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

Oct 8, 2020

Castle Bio Receives Expanded Medicare Coverage for Melanoma Test

Sep 4, 2020

People in the News: New Appointments at Castle Biosciences, Akoya Biosciences, Syapse, More

Aug 10, 2020

Castle Biosciences Q2 Revenues Up 18 Percent

Jun 25, 2020

Castle Biosciences Prices $74M Public Offering

May 11, 2020

Castle Biosciences Doubles Q1 Revenues

Apr 3, 2020

People in the News: Kim Popovits, Miles Harrison, Matt Sargent, More

Mar 10, 2020

Castle Biosciences Q4 Revenues Increase 54 Percent, Full-Year 2019 Revenues More Than Double

Feb 3, 2020

Illumina Stock Drags GenomeWeb Index Down in January

Jan 9, 2020

Castle Biosciences Reports Preliminary Q4 Melanoma Test Results Up 37 Percent

Jan 2, 2020

Qiagen Stock Tanks in December, Fluidigm Shares Soar as GenomeWeb Index Ends 2019 on High Note

Nov 11, 2019

Castle Biosciences Q3 2019 Revenues Quadruple

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.